EN | UA
EN | UA

Help Support

Back

Can CCL2 and CXCL10 levels in maternal serum predict risk of preterm birth?

preterm birth preterm birth
preterm birth preterm birth

What's new?

In high-risk pregnant women, CCL2 exhibits the strongest predictive ability for delivery within seven days, while CXCL10 demonstrates superior long-term predictive ability for delivery before 34 weeks.

In a prospective cohort study, low maternal serum CC-chemokine-ligand 2 (CCL2) levels correlated with an increased risk of preterm birth within 7 days in high-risk pregnant women. Elevated CXC-chemokine-ligand 10 (CXCL10) serum levels were more indicative of a heightened risk for preterm birth before 34 weeks. The heightened CXCL10/CCL2 ratio demonstrated the most reliable predictive performance.

Researchers sought to assess whether chemokines like CCL2 and CXCL10 could predict the risk of spontaneous preterm birth in a cohort of symptomatic high-risk pregnant women. Overall, 109 females exhibiting preterm labor signs between 20 + 0 and 31 + 6 weeks of pregnancy were recruited in the study. The inclusion criteria encompassed a history of previous preterm birth, cervical length less than 25 mm, or painful contractions or regular contractions (less than 3 in 30 minutes).

Blood samples were collected upon the initial admission, and biomarker concentrations were determined utilizing pre-coated sandwich immunoassays (enzyme-linked immunosorbent assay [ELISA]). The major endpoint of the study was spontaneous preterm birth before 34 weeks, while the secondary endpoint was delivery before 37 weeks or within 7 days following study inclusion. A total of 16 women (14.7%), delivered before 34 weeks, while twenty women (18.4%), gave birth between 34 + 0 and 36 + 6 weeks.

Additionally, 6 subjects (5.5%) delivered within 7 days following study admission. Women experiencing preterm birth before 34 weeks exhibited higher medium serum levels of CXCL10 (115 pg/ml) compared to those delivering at or beyond 34 weeks (61 pg/ml). Similarly, CXCL10 levels were higher in women delivering before 37 weeks (103 pg/ml vs. 53 pg/ml). In contrast, reduced levels of CCL2 in maternal serum were linked with delivery within seven days (25 pg/ml vs. 73 pg/ml) and preterm birth before 34 weeks (46 pg/ml vs. 73 pg/ml).

The CXCL10/CCL2 ratio enhanced the predictive model, yielding an area under the receiver operating characteristic curve (ROC-AUC) of 0.83 for delivery before 34 weeks, corresponding to positive predictive value, specificity, and sensitivity of 0.43, 0.86, and 0.67, respectively, at a cut-off of 2.2. Both chemokines were favorable in the longer-term prediction of preterm birth.

Source:

BMC Pregnancy and Childbirth

Article:

Prediction of spontaneous preterm birth using CCL2 and CXCL10 in maternal serum of symptomatic high-risk pregnant women: a prospective cohort study

Authors:

Jessica Alana Hoffmann et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: